上海招聘

本生药业（上海）有限公司成立于2015年8月，是一家专业从事具有自主知识产权、致力于天然产物的化合物为核心的新药研发。通过开创全新的新药研发模式，缩短研发周期，降低研发成本，研发高药效、低毒性的国际一流新型抗肿瘤药物。
公司已拥有自主知识产权BS-HH-002的美国、中国、日本、欧洲专利。该化合物已完成临床申报工作。


Founded in August 2015, Bensheng Pharmaceutical (Shanghai) Co., Ltd. is a company specialized in new drug research and discovery based on natural product compounds with independent intellectual property rights. By creating a new model of new drug research and development, shortening the R&D cycle, reducing R&D costs, Bensheng is committed to develop world-class new antitumor drugs with high efficacy and low toxicity.
The company has independent intellectual property rights of BS-HH-002, we have already got the patents of the United States, China, Japan, Europe of BS-HH-002. The investigational new drug application of the compound has already been completed and approved.


公司网站：www.benshengpharma.com